A Cell-Penetrating Peptide Improves Anti-HER2 Single-Chain Variable Fragment Internalization and Antitumor Activity against HER2-Positive Breast Cancer In Vitro and In Vivo
Molecules · 2024
DOI: 10.3390/molecules29061247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Junmin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE International Joint Laboratory for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Techn…. Hauptthemen laut MEDLINE: Breast Neoplasms, Single-Chain Antibodies, Cell-Penetrating Peptides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Projects, the Guangdong Provincial Medical Products Administration, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Cell-penetrating peptides (CPPs) are invaluable tools for delivering various substances into cells by crossing biological membranes. However, the effects of cell-penetrating peptide fusion proteins on the biological activity of antibodies remain to be fully understood. Here, we engineered a recombinant protein, LP-scFv, which combines the single-chain variable region of anti-human epidermal growth factor receptor-2 with a novel and non-oxic cell-penetrating peptide as a leader peptide. The introduction of this leader peptide led to a more than twofold increase in the internalization efficiency of the single-chain antibody, as confirmed using microscopic analysis and flow cytometry. The effects of the single-chain antibodies and LP-scFv on cell viability were evaluated using the MTT assay. Both the single-chain antibodies and LP-scFv reduced the viability of BT474 and NCI-N87 cells in a dose-dependent manner while exhibiting minimal toxicity towards MCF-7 and MCF-10A cells. Further investigation into LP-scFv’s mechanism revealed that the induced leader peptide does not alter the MAPK-ERK1/2 and PI3K/AKT pathways of single-chain antibodies. An enhanced antitumor activity was also confirmed in an NCI-N87 tumor xenograft model in mice with a reduction of 45.2% in tumor growth inhibition (vs. 23.1% for scFv) with a 50 mg/kg dose after orthotopic injection administration, which was equivalent to that of trastuzumab (vs. 55.7% for trastuzumab). Overall, these results indicate that LP-scFv exhibits significant permeation activity in HER2-positive cells to enhance the intracellular dose effect on antitumor activity in vitro and in vivo. This research lays the foundation for designing novel antibody-based therapies for cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE International Joint Laboratory for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
- School of Biology and Food Science, Shangqiu Normal University, Shangqiu 476000, China.
- Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou, University of Chinese Medicine, Guangzhou 510006, China.
- Nanyang Medical College, Nanyang 473001, China.
- NMPA Key Laboratory for Quality Control of Blood Products, Guangdong Institute for Drug Control, Guangzhou 510663, China.
ORCID-Profile: Lei Zhang
Förderung
- the National Key R&D Projects
- the Guangdong Provincial Medical Products Administration
- Basic and Applied Basic Research Foundation of Guangdong Province
- Special project for Research and Development in Key areas of Guangdong Province
- Natural Science Foundation of Henan Province
- Key Scientific Research Project in Universities of Henan Province
- National Key R&D Projects
- Guangdong Provincial Medical Products Administration
Zitieren
APA
Li, J., Zhou, Y., Su, Z., Li, X., Zhang, L., & Li, S. (2024). A Cell-Penetrating Peptide Improves Anti-HER2 Single-Chain Variable Fragment Internalization and Antitumor Activity against HER2-Positive Breast Cancer In Vitro and In Vivo. Molecules. https://doi.org/10.3390/molecules29061247
Vancouver
Li J, Zhou Y, Su Z, Li X, Zhang L, Li S. A Cell-Penetrating Peptide Improves Anti-HER2 Single-Chain Variable Fragment Internalization and Antitumor Activity against HER2-Positive Breast Cancer In Vitro and In Vivo. Molecules. 2024. doi:10.3390/molecules29061247
BibTeX
@article{Li2024,
author = {Li, Junmin and Zhou, Yanting and Su, Zhuowei and Li, Xue and Zhang, Lei and Li, Shan},
title = {A Cell-Penetrating Peptide Improves Anti-HER2 Single-Chain Variable Fragment Internalization and Antitumor Activity against HER2-Positive Breast Cancer In Vitro and In Vivo},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29061247}
}
EUVIMED